These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 8325116)
1. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Kline JN; Schwartz DA; Monick MM; Floerchinger CS; Hunninghake GW Chest; 1993 Jul; 104(1):47-53. PubMed ID: 8325116 [TBL] [Abstract][Full Text] [Related]
2. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Janson RW; King TE; Hance KR; Arend WP Am Rev Respir Dis; 1993 Aug; 148(2):495-503. PubMed ID: 8342915 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Mikuniya T; Nagai S; Shimoji T; Takeuchi M; Morita K; Mio T; Satake N; Izumi T Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):39-45. PubMed ID: 9186988 [TBL] [Abstract][Full Text] [Related]
4. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Nagai S; Aung H; Takeuchi M; Kusume K; Izumi T Chest; 1991 Mar; 99(3):674-80. PubMed ID: 1995225 [TBL] [Abstract][Full Text] [Related]
5. [Quantitative evaluation of gene expression of IL-1 beta and IL-1 receptor antagonist (IL-1ra) from alveolar macrophages in idiopathic pulmonary fibrosis (IPF) and sarcoidosis]. Shimoji T; Nagai S; Takeuchi M; Saito A; Izumi T Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1409-15. PubMed ID: 8277611 [TBL] [Abstract][Full Text] [Related]
6. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta. Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912 [TBL] [Abstract][Full Text] [Related]
7. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. Oltmanns U; Schmidt B; Hoernig S; Witt C; John M Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045 [TBL] [Abstract][Full Text] [Related]
8. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. Zhang Y; Lee TC; Guillemin B; Yu MC; Rom WN J Immunol; 1993 May; 150(9):4188-96. PubMed ID: 8473757 [TBL] [Abstract][Full Text] [Related]
9. [Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure]. Tokuyama T; Yoneda T; Tamura M; Tsukaguchi K; Yoshikawa M; Tou R; Narita N; Kasuga H; Miyazaki R Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):193-8. PubMed ID: 8515598 [TBL] [Abstract][Full Text] [Related]
10. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Pueringer RJ; Schwartz DA; Dayton CS; Gilbert SR; Hunninghake GW Chest; 1993 Mar; 103(3):832-8. PubMed ID: 8449077 [TBL] [Abstract][Full Text] [Related]
11. Alveolar macrophage cytokine and growth factor production in a rat model of crocidolite-induced pulmonary inflammation and fibrosis. Driscoll KE; Maurer JK; Higgins J; Poynter J J Toxicol Environ Health; 1995 Oct; 46(2):155-69. PubMed ID: 7563215 [TBL] [Abstract][Full Text] [Related]
12. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444 [TBL] [Abstract][Full Text] [Related]
13. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Schaberg T; Rau M; Stephan H; Lode H Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1507-13. PubMed ID: 8099261 [TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. Smith DR; Kunkel SL; Standiford TJ; Rolfe MW; Lynch JP; Arenberg DA; Wilke CA; Burdick MD; Martinez FJ; Hampton JN Am J Respir Crit Care Med; 1995 Jun; 151(6):1965-73. PubMed ID: 7767546 [TBL] [Abstract][Full Text] [Related]